Study title: A double-blind, randomized, cross-over studytTo determine whether the inhaled glucocorticoid BUD has any adverse effect on short-term linear growth in 15 children (6-13 years) with mild asthma.
Type of medicine: Medicines containing chemical active substances | |||||
Therapeutic area: Respiratory Tract Diseases [C08] | |||||
Brands: Please see report | |||||
MAH holders: Please see report | |||||
Assessment: | |||||
Active substance: BUDESONIDE | |||||
ATC code: | |||||
Document link: | |||||
Document date: 2014-10-17 | |||||
Study number: 04-2260 | |||||
EudraCT number: | |||||
Scope of study: Clinical | |||||
Population of study subjects: | Preterm newborn Infants | Newborn infants (1 to 27 days) | Infants and toddlers (28 days to 24 months) | Children (2 to 11 years) | Adolescents (12 to 18 years) |
- | - | - | Y | Y |